Notice: This company has been marked as potentially delisted and may not be actively trading. MyoKardia (MYOK) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024November 13, 2024 | markets.businessinsider.comBristol's New Schizophrenia Drug Cobenfy Helps Support Its Wide MoatNovember 12, 2024 | morningstar.comHealthEx Raises $14M led by General Catalyst to Empower Patients and Health Systems to do more with Health DataOctober 21, 2024 | markets.businessinsider.comMavacamten Shows Promise in Heart Failure With Normal to Supranormal EFOctober 1, 2024 | msn.comBristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)September 27, 2024 | seekingalpha.comSepterna Marks Transition to a Clinical-Stage Company with Appointments of Industry Veterans in Key Drug Development RolesSeptember 25, 2024 | finance.yahoo.comAstria Therapeutics expands board with new directorApril 11, 2024 | uk.investing.comAstria Therapeutics Appoints Sunil Agarwal to Its Board of DirectorsApril 9, 2024 | finance.yahoo.comFULC Fulcrum Therapeutics, Inc.March 27, 2024 | seekingalpha.comCytokinetics: CEO Talks Down Buyout ProspectsMarch 16, 2024 | seekingalpha.comQ4 2023 Fulcrum Therapeutics Inc Earnings CallFebruary 27, 2024 | uk.finance.yahoo.comFulcrum Therapeutics Inc (FULC) Reports Financial Results for Q4 and Full Year 2023February 27, 2024 | finance.yahoo.comFulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023February 27, 2024 | markets.businessinsider.comIf heart disease runs in your family, talk to your doctor about HCMFebruary 16, 2024 | cbsnews.comBristol Myers pours $100M into RNA drugs for cardiovascular diseasesNovember 29, 2023 | finance.yahoo.comAvidity and BMS enter $2.3bn deal for cardiovascular targetsNovember 29, 2023 | msn.comWhy Is RNA Therapeutics-Focused Avidity Biosciences Stock Trading Higher Today?November 28, 2023 | msn.comAvidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone paymentsNovember 28, 2023 | msn.comHow Viz.ai Uses Artificial Intelligence To Treat Stroke Patients FasterNovember 22, 2023 | forbes.comWhy LianBio Stock Is Ripping Higher TodayOctober 24, 2023 | benzinga.comWhy Is LianBio (LIAN) Stock Up 130% Today?October 24, 2023 | msn.comWhy LianBio Stock Is Skyrocketing TodayOctober 24, 2023 | msn.comLianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian MarketsOctober 24, 2023 | finance.yahoo.comBristol Myers (BMY) to Acquire Mirati Therapeutics for $5.8 BOctober 9, 2023 | msn.comPeninsula biotech company looks to pump new life into heart disease treatmentsOctober 4, 2023 | bizjournals.comFulcrum Therapeutics (FULC) Price Target Increased by 30.97% to 10.78August 31, 2023 | msn.comCutera, Inc. Appoints Taylor Harris as Chief Executive OfficerJuly 27, 2023 | finance.yahoo.comCutera Names Taylor Harris As CEO, Shares GainJuly 27, 2023 | markets.businessinsider.comCutera Names Taylor Harris CEO, Ending Succession Tussle >CUTRJuly 27, 2023 | marketwatch.comAbivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of DirectorsJuly 11, 2023 | finance.yahoo.comEQS-News: Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of DirectorsJuly 11, 2023 | markets.businessinsider.comKorporatsiya VSMPO AVISMA PAO (VSMO)July 10, 2023 | investing.comHypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2023June 9, 2023 | uk.finance.yahoo.com3 Dividend Stocks You Can Buy Without Any HesitationJune 3, 2023 | msn.comTenaya Therapeutics, Inc.: Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 11, 2023 | finanznachrichten.deLianBio Announces Marketing Approval of CAMZYOS(R) (mavacamten) in the Macau Special Administrative Region (SAR) of ChinaMay 11, 2023 | marketwatch.comTenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 10, 2023 | technews.tmcnet.comDiabetes Drug Therapy Market Analysis Report focuses on the remarkable market size CAGR rate of 4.6% for period from 2023 and 2030.April 13, 2023 | marketwatch.comBrain Ischemia market research report will assist market stakeholders in analysing the growing CAGR of 5.1% to make more informed decisions.April 13, 2023 | marketwatch.comThe report on the Potassium Channel Blocker market assesses the competition, their advantages, and drawbacks, and predicts a CAGR of 5.3% by 2030.April 9, 2023 | marketwatch.comREGENCOR EXPANDS SCIENTIFIC ADVISORY BOARDMarch 24, 2023 | benzinga.comCytokinetics heart failure drug turned back by FDAMarch 3, 2023 | bizjournals.comDilated Cardiomyopathy Therapeutics Market Size, Share and Forecast 2028 with Top Countries DataFebruary 24, 2023 | marketwatch.comDilated Cardiomyopathy Therapeutics Market 2023: Growth Outlook and Forecast 2027 with Top Leaders, Size and Share AnalysisFebruary 6, 2023 | marketwatch.comMaze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chief Medical Officer - Yahoo FinanceOctober 13, 2022 | finance.yahoo.comMaze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chie - BenzingaOctober 13, 2022 | benzinga.comGot $5,000? These 2 Stocks Could Continue Beating the Bear Market. - NasdaqOctober 12, 2022 | nasdaq.comBristol-Myers Squibb: A Gem Amid Macroeconomic Uncertainties - Seeking AlphaOctober 2, 2022 | seekingalpha.comArthur Tzianabos, Ph.D., June Lee, MD FACCP, and Joseph Loscalzo, MD, Ph.D. Join 5AM Ventures - StreetInsider.comSeptember 27, 2022 | streetinsider.comBristol Myers Squibb Stock: Still A Buy Despite Some Concerns (NYSE:BMY) - Seeking AlphaSeptember 11, 2022 | seekingalpha.com Get MyoKardia News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOK and its competitors with MarketBeat's FREE daily newsletter. Email Address MYOK Media Mentions By Week MYOK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYOK News Sentiment▼0.000.55▲Average Medical News Sentiment MYOK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYOK Articles This Week▼00▲MYOK Articles Average Week Get MyoKardia News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TAK News Today ALNY News Today TEVA News Today BGNE News Today RPRX News Today UTHR News Today GMAB News Today VTRS News Today ITCI News Today SMMT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYOK) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyoKardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyoKardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
